Quest for the right Drug
ויווטיף VIVOTIF (VIABLE SALMONELLA TYPHI TY21A CELLS)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
אין פרטים : GASTRO RESISTANT HARD CAPSULE
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Posology : מינונים
4.2 Posology and method of administration Posology One capsule of Vivotif is taken on each of Days 1, 3 and 5. Complete vaccination comprises the ingestion of three capsules as described above. The optimal immune response may not be achieved unless the entire vaccination schedule is completed. Protection against typhoid fever commences approximately seven to ten days after ingesting the third dose of vaccine. The entire vaccination schedule should be completed at least one week prior to travel to an endemic area. Revaccination Revaccination is recommended at three years following the most recent vaccination for all individuals. Revaccination comprises the ingestion of three capsules on Days 1, 3, and 5, as for the original vaccination schedule. Paediatric Population Vivotif is not indicated for children under 5 years of age. The posology in children is the same as in adults. Safety and efficacy in children under five years of age have not been established. Method of administration One capsule of Vivotif is taken with cold or lukewarm water (temperature not more than 37°C) on an empty stomach and at least one hour before the next meal. The vaccine capsule should not be chewed and should be swallowed as soon as possible after placing in the mouth.
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
ATC
מידע נוסף